amobarbital has been researched along with Arterial Occlusive Diseases in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hacke, W | 1 |
| Hündgen, R | 1 |
| Zeumer, H | 1 |
| Ferbert, A | 1 |
| Buchner, H | 1 |
1 other study available for amobarbital and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Monitoring of therapeutic neuroradiologic examination and therapeutic procedures using evoked potentials].
Topics: Amobarbital; Angioplasty, Balloon; Antineoplastic Agents; Arterial Occlusive Diseases; Embolization, | 1985 |